Home CGT Industrial Park Tour Series Stop Six: Beijing Yichuang High-Tech Innovation Science Park

CGT Industrial Park Tour Series Stop Six: Beijing Yichuang High-Tech Innovation Science Park

Feb 23, 2024 14:37 CST Updated 14:37
Yeasen

Tool Enzyme Raw Materials and Diagnostic Product R&D, Manufacturer

VectorBuilder

Gene Delivery Technology Developer

Saifu Pharmaceutical

Preclinical CRO Service Provider

Legend Capital

Early-stage venture capital and growth-stage private equity investment institutions

亦创主K.jpg

Event Information


■ Stop 6: Beijing Yichuang Gaoke Innovation and Technology Park


Event Duration: March 7, 2024 (Thursday) 13:30
Venue: Lecture Hall, 1st Floor, Building 4, Yichuang Gaoke Innovation Technology Park, No. 2 Courtyard, Kechuang 6th Street, Beijing Economic-Technological Development Area
OrganizerHealthcare Innovative Ecosystem Alliance (HIEA)
Co-Hosted By: Hangzhou Xingcheng Biotechnology, Yeasen, LePure Introduction, Austar Group (Hong Kong), VectorBuilder, Beijing T&L Biotechnology, Saifu Pharmaceutical, Legend Capital
Organizer: Arterial New Medicine
Supporting Organizations: Yichuang High-Tech Innovation Park


Since November 2023, VBInsight, in collaboration with enterprises across the CGT industry chain, has held four “CGT Industry Upgrade Park Tour” events in Shanghai Zhangjiang, Shanghai Free Trade Zone No.1, Nanjing Bio-Medicine Valley, and Suzhou BioBAY. These events brought together decision-makers from innovative CGT companies and service providers across the industry chain to voice their needs, engage in candid discussions, and foster communication, networking, and co-creation of high-quality products.

Amid the ongoing capital winter, strengthening CMC capabilities, exploring financing opportunities, pursuing international expansion, and maintaining survival resilience have become core strategic issues that innovative pharmaceutical companies urgently need to address.

Based on this, byHosted by the Healthcare Innovative Ecosystem Alliance (HIEA), co-hosted by Hangzhou Xingcheng Biotechnology Co., Ltd., Yeasen, LePure Introduction, Austar Group, VectorBuilder, Beijing T&L Biotechnology Co.,Ltd., Saifu Pharmaceutical, and Legend Capital, and organized by VCBeat New Medicine.“ [Go Further Without the Rat Race] CGT Industry Upgrade Series · Park Tour Stop 6 will be held on March 7 (Thursday) at Yichuang Gaoke Innovation Technology Park in Yizhuang, Beijing.

Share Highlights


CGT from an Investment Perspective: Leveraging investor acumen to distill new pathways for capital operations by innovative pharmaceutical companies through discussions on investment and financing strategies in the CGT sector, thereby empowering enterprises to seize growth opportunities and navigate challenges.

Supply Chain Best Practices: Listen to the needs of Party A, and supply chain enterprises work together to explore the most suitable solutions, striving to help innovative companies transition smoothly, quickly, and cost-effectively from IND to BLA.

BD Strategy Essentials: The BD Wisdom of Innovative Pharmaceutical Companies: Profoundly Insightful into the Global Cooperation Context, Precisely Capturing Opportunities in Emerging Markets. A BD Guide Combining Strategic Height and Practical Experience, Providing Valuable Insights for Pharmaceutical Pioneers Committed to Global Development.

The “Yichuang High-Tech Innovation Science Park Tour” marks the sixth stop in our series of park visits. Similar events will be held in other industrial parks in the future to promote the continuous upgrading and development of the CGT industry. We look forward to engaging in discussions and making progress together with industry peers, helping the CGT sector go further!

Event Agenda


■ 13:30-13:40 Opening Remarks by the Moderator + Introduction to the Ecosystem
Moderator | Event Expectations and Ecosystem Synergy

■ 13:40-14:00
Keynote Speech 1 |Rotating Co-organizer Keynote Presentation

■ 14:00-15:10
Panel 1 | How to Partner with CGT Companies to Navigate from IND to BLA: Stable, Fast, and Cost-Effective?
Introduction to Core Competencies and Service Value
How to Engage Constructively with Clients and Foster Mutual Support

■ 15:10-16:10
Panel 2 | Discussing Industrial Upgrading: Key CMC Points and Solutions for Gene and Cell Therapy
Beyond Generic Regulatory Discussions
Discussion on Quality Control Strategies and Specific Service Cases
Party A states its requirements; Party B proposes solutions.

■ 16:10-16:30 Tea Break

■ 16:30-16:50
Keynote Speech 2 |Progress and Trends in the CGT Industry: An Investment Perspective
Finance as a Tool: Understanding Capital Market Trends
Industry as the Foundation: Current Status and Outlook of the CGT Sector

■ 16:50-17:10
Dialogue with Large Enterprises |Enterprise Perspective: Making Innovation Sustainable

■ 17:10-18:10
Panel 3 | How Can CGT Companies Effectively “Raise and Spend Capital” in the New Landscape?
Say Goodbye to Cookie-Cutter Roadshows with Random Conversations
Insights and Perspectives: Helping Enterprises Demonstrate Value
"Prepare," Respect Uncertainty
Innovative One-to-Many Interview-Style Project Pitch

■ 18:30–20:30 Dinner Reception (By Invitation Only)


Event Scale: 50 people/session
Event Collaboration:
Ms. Fu 17851017836 (WeChat ID same)
Event Registration:

Capillary 17782369627 (WeChat ID same)


Scan the QR Code to Register

小助手.jpg

亦创海报.jpg